Mirum Pharmaceuticals (MIRM) Raw Materials (2021 - 2026)

Mirum Pharmaceuticals' Raw Materials history runs 6 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Raw Materials fell 13.68% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 13.68% YoY), while the FY2025 annual figure was $2.9 million, down 4.36% from the prior year.
• Raw Materials for Q1 2026 stood at $2.6 million, down from $2.9 million in the prior quarter.
• The five-year high for Raw Materials was $3.0 million in Q4 2024, with the low at $444000.0 in Q3 2023.
• The 5-year median for Raw Materials is $2.9 million (2024), against an average of $2.5 million.
• The sharpest annual moves came in 2024 and 2026: Raw Materials soared 528.38% in 2024, then dropped 13.68% in 2026.
• Mirum Pharmaceuticals' Raw Materials stood at $858000.0 in 2022, then jumped by 249.42% to $3.0 million in 2023, then advanced by 1.07% to $3.0 million in 2024, then dropped by 4.36% to $2.9 million in 2025, then dropped by 9.87% to $2.6 million in 2026.
• Business Quant data shows MIRM's Raw Materials at $2.6 million in Q1 2026, $2.9 million in Q4 2025, and $2.9 million in Q3 2025.